Both in Pharmaceuticals
Pasithea Therapeutics vs Neuphoria Therapeutics
Over the past year KTTA returned −54.6% and NEUP returned −30.4%; their daily moves had a correlation of 0.04.
KTTA −54.6% NEUP −30.4%Growth of $1, one year, split-adjusted
| Metric | KTTA | NEUP |
|---|---|---|
| Price | $0.3700 | $3.05 |
| Market cap | $12.4M | $16.5M |
| Today | −0.04% | 0.00% |
| 1 month | −22.3% | −12.1% |
| 6 months | −56.3% | −42.3% |
| Year to date | −71.3% | −21.4% |
| 1 year | −55.8% | −30.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $45.7M | — |
| Dividend yield | — | — |
| Volatility (60d) | 72.5% | 27.8% |
| Short % of float | 0.5% | 0.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).